A preliminary study of diagnosing prostate cancer with quantitative analysis of dynamic contrast-enhanced MR at 3. 0 T
10.3760/cma.j.issn.1005-1201.2011.01.011
- VernacularTitle:3.0 T MR动态增强扫描定量分析诊断前列腺癌的初步研究
- Author:
Chunmei LI
;
Min CHEN
;
Saying LI
;
Xuna ZHAO
;
Chen ZHANG
;
Cheng ZHOU
- Publication Type:Journal Article
- Keywords:
Prostate neoplasms;
Magnetic resonance imaging;
Comparative study
- From:
Chinese Journal of Radiology
2011;45(1):50-54
- CountryChina
- Language:Chinese
-
Abstract:
Objectives To investigate the feasibility of the quantitative analysis parameters of dynamic contrast-enhanced MRI (DCE-MRI) in the diagnosis of prostate cancer and to correlate Ktrans, Ve and kep with histological grade (Gleason score) and serum prostate specific antigen (PSA). Methods MR examinations were performed in 38 patients confirmed by biopsy. ROI were drawn on areas of cancerous foci,noncancerous foci in the peripheral zone and central gland to measure the values of Krans, Ve and kep. The values of the three parameters in different tissue were compared with ANOVA. The correlations between the pharmacokinetic parameters and Gleason score, PSA were assessed with Pearson correlation. Results The Ktrans, Ve, kep values of cancerous foci were (0. 35 ± 0. 26 )/min, ( 0. 185 ± 0. 080 ), ( 1.42 ± 0. 53 )/min,respectively, while (0. 07 ± 0. 05 )/min, ( 0. 040 ± 0. 024 ), (0. 50 ± 0. 18 )/min for noncancerous foci in the peripheral zone and (0. 19 ±0. 06)/min, (0. 161 ± 0. 062), (0. 94 ±0. 25) /min for noncancerous foci in the central gland, respectively. The differences between the three parameters of cancerous foci,noncancerous foci in the peripheral zone and central gland were statistically significant ( F = 16. 267,44. 084, 36. 095, respectively; P ＜ 0. 01 ). No significant correlations were found between any parameter and either Gleason score or PSA (r =0. 279,0.069, 0. 109, -0. 175, -0.067,0. 137, respectively;P ＞0. 05). Conclusion Quantitative analysis parameters of DCE-MRI are feasible in diagnosing prostate cancer. They may be useful in differentiating prostate cancer from benign prostatic diseases.
